SATISH ANGRA: Open Payments
NPI 1992810550 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 44 payments from 15 companies in 2025. Trend: 2023 $1,159 · 2024 $986 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $193 |
| Cumberland Pharmaceuticals, Inc. | 7 | $164 |
| Inspire Medical Systems, Inc. | 1 | $143 |
| GlaxoSmithKline, LLC. | 7 | $138 |
| ABBVIE INC. | 3 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| Amgen Inc. | 3 | $55 |
| Gilead Sciences, Inc. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Novo Nordisk Inc | 2 | $32 |
Products named: JARDIANCE, KRISTALOSE, INSPIRE, TRELEGY ELLIPTA, Kerendia, UBRELVY, OTEZLA, ULTOMIRIS.
Industry payments across MD — which companies pay providers there.
